New updates have been reported about Octane.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Octane is using its 2026 Neuro Tech Forum to reinforce its role as a capital and connectivity hub for Southern California’s neurotechnology sector, convening investors, clinicians, and founders in Newport Beach on March 26–27, 2026. Positioned as part of Octane’s Innovation Event Series, the forum is designed to surface investable technologies, foster strategic partnerships, and channel resources into regional neurotech ventures.
The event will feature a keynote from Dr. Adnan Siddiqui of the Jacobs Institute, whose work on translating vascular and neuroendovascular innovations into commercial therapies aligns with Octane’s focus on accelerating commercialization pathways. Additional speakers from investment firms, device companies, and clinical leaders will frame current neurotech trends and unmet needs, providing deal-flow and diligence context for capital allocators engaging with Octane’s ecosystem.
Operationally, Octane’s COO Janelle Brunette will open the conference, signaling the forum’s integration with Octane’s broader platforms, including its LaunchPad accelerator, Octane Capital & Growth services, and Ignite Series content offerings. CEO Bill Carpou positions the forum as a “one-stop platform” intended to strengthen the neurotech industry’s ecosystem at a time of rising cost pressures and structural challenges in global healthcare.
For executives and investors, the forum functions as both a sourcing mechanism and a network amplifier, potentially feeding high-potential companies into LaunchPad and connecting them with Octane’s capital and growth advisory channels. The gathering should enhance Octane’s visibility with institutional and strategic investors interested in medtech and neurotech, while reinforcing its brand as a central convenor for SoCal innovation.
While no direct revenue figures or funding announcements were disclosed, the scale and caliber of participants indicate the event is a strategic asset that can generate future pipeline for Octane’s programs and its corporate and investor partners. Over time, repeated execution of such specialized forums may translate into greater deal volume, deeper investor relationships, and increased throughput of medtech and neurotech companies across Octane’s platform.